indazoles has been researched along with Hypomelanosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blasco Cordellat, A; Camps Herrero, C; Meri-Abad, M | 1 |
| Pavlović, M; Šeparović, R; Silovski, T; Tečić Vuger, A | 1 |
| Bible, KC; Burton, JK; Erlichman, C; Ivy, SP; Menefee, ME; Sideras, K | 1 |
3 other study(ies) available for indazoles and Hypomelanosis
| Article | Year |
|---|---|
[Capillary and cutaneous hypopigmentation secondary to pazopanib].
Topics: Humans; Hypopigmentation; Indazoles; Pyrimidines; Sulfonamides | 2022 |
Rapid hair depigmentation in patient treated with pazopanib.
Topics: Hair; Hair Color; Humans; Hypopigmentation; Indazoles; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides | 2018 |
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib.
Topics: Adenoma, Oxyphilic; Adult; Black or African American; Female; Hair; Humans; Hypopigmentation; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Skin; Sulfonamides; Thyroid Neoplasms | 2010 |